SMi 4th Annual Conference on Neurodegenerative Disorders: a focus on Alzheimer’s and Parkinson’s disease

By O’Neill Michael J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1369-1373

Informa Healthcare

Access to resources Recommend Favorite

Non-oral drug delivery in Parkinson’s disease: a summary from the symposium at the 7th International Congress of Parkinson’s Disease and Movement Disorders

By Behrens Stephan   Sommerville Kenneth  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 595-599

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer’s Disease and Parkinson’s Disease: A Review of Current Treatment Adopting a Nanotechnology Approach

By  

Current Pharmaceutical Design, Vol. 24, Iss. 1, 2018-03 ,pp. : 22-45

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Conference Report: 10th Clinical Trials on Alzheimer's Disease (CTAD), Boston MA, USA, November 1-4, 2017

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 10, 2018-03 ,pp. : 1134-1137

Bentham Science Publishers

Access to resources Recommend Favorite